Consensus EPS · Q2 2026
$1.04
Consensus revenue · Q2 2026
$3.1B
Analysts
9
Expected report
Aug 6, 2026
What to watch
- Analyst ratings: Mixed
Analyst consensus
Based on estimates from 9 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $2.8B | $3.1B | $3.4B |
| EPS | $0.92 | $1.04 | $1.25 |
| EBITDA | $1.2B | $1.2B | $1.2B |
| EBIT | $669.6M | $680M | $692.6M |
| Net income | $631.6M | $686.5M | $727.7M |
- Revenue$3.1B
- EPS$1.04
- EBITDA$1.2B
- EBIT$680M
- Net income$686.5M
Historical beat/miss
Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.
| Period | Rev. actual | Rev. est. | Rev. surprise | EPS actual | EPS est. | EPS surprise |
|---|---|---|---|---|---|---|
| Q1 2026 | $3.7B | $4.1B | -10.9% | $1.51 | $1.51 | -0.3% |
- Q1 2026-10.9%-0.3%
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
Revision trends appear once we have collected at least two daily snapshots for this period.
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
Be the first to predict
No community consensus for Sempra (SRE) Q2 2026 yet. Make a prediction to start the crowd forecast.
Analyst price target
Based on price targets from 5 analysts.
- Low
- $101.00
- Consensus
- $106.00
- Median
- $103.50
- High
- $118.00
- Current
- $93.05
- Upside
- +13.9%
Upside calculated vs most recent trading price of $93.05.
Analyst ratings
Consensus: Buy — based on 26 analyst ratings.
24-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 9, 2026 | Barclays | maintain | Overweight | Overweight |
| May 18, 2026 | Truist Securities | maintain | Buy | Buy |
| May 11, 2026 | BMO Capital | maintain | Outperform | Outperform |
| Apr 21, 2026 | Morgan Stanley | maintain | Overweight | Overweight |
| Apr 15, 2026 | Barclays | maintain | Overweight | Overweight |
| Mar 23, 2026 | Wells Fargo | maintain | Overweight | Overweight |
| Mar 18, 2026 | JP Morgan | maintain | Overweight | Overweight |
| Mar 6, 2026 | UBS | maintain | Neutral | Neutral |
| Mar 5, 2026 | Evercore ISI Group | maintain | Outperform | Outperform |
| Mar 4, 2026 | Argus Research | upgrade | Hold | Buy |
- Jul 9, 2026BarclaysOverweight
- May 18, 2026Truist SecuritiesBuy
- May 11, 2026BMO CapitalOutperform
- Apr 21, 2026Morgan StanleyOverweight
- Apr 15, 2026BarclaysOverweight
- Mar 23, 2026Wells FargoOverweight
- Mar 18, 2026JP MorganOverweight
- Mar 6, 2026UBSNeutral
- Mar 5, 2026Evercore ISI GroupOutperform
- Mar 4, 2026Argus ResearchBuy
Frequently asked questions
Sempra (SRE) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks1.45% TTM
- Dividend Profile2.80% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History3 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.